Readiness assessment
Healthcare & Pharma · Diagnostics

The DPDP Act for Diagnostics & Labs

Diagnostic centres generate some of the most revealing health data there is, and share it across patients, doctors and aggregators.

In short

Labs and diagnostic centres are Data Fiduciaries for test results, imaging and genetic data. The Act requires clear consent, minimal collection, secure sharing across every channel, and defined retention. Penalties reach ₹250 crore.

Core impacts

What changes for this sub-sector.

Consent for testing and sharing

Consent to run a test is not automatic consent to share results with aggregators or to market to the patient.

Result-sharing channels

Reports sent by SMS, email, portals or messaging apps must be secured and access-controlled.

Home collection and partners

Phlebotomy apps and sample-collection partners are processors you remain liable for.

Data minimization

Collect only what the test and report need; do not bundle unrelated data.

Retention and erasure

Keep results for the required clinical and legal period, then delete.

Patient rights

Patients can access and correct their results and withdraw consent for further use.

Go deeper

Niche guides for this area, each naming the specific regulation.

Check your reporting flow.

The readiness check flags sharing-channel, consent-scope and retention gaps.

Take the readiness check